About the AGS-004 phase 2a study in HIV – Approximately 34 patients with HIV ART will currently receive will the the Phase 2a study. The study will be performed at up to 15 sites in North America. The primary objective of the study is to evaluate the effectiveness of AGS-004 therapy in improving immune control of HIV – 1 replication. Secondary objectives are to evaluate the safety and tolerability of AGS-004, exploring its immunologic activity and the study of the mechanism of action for AGS-004. This study Canadian Institutes Canadian Institutes of Health Research, Canadian Clinical Trials Network and the National Institutes of Health . AGS AGS-004 is part of the ‘broad collaboration with Kirin Pharma Company, Ltd..
Early and consistent stimulation of the part of the inner ear known as the cochlea is critical to a child’s development of speech and language disorders, according to background information in the article. Bone-anchored hearing aids, structures temporal bone temporal bone of the skull surgically treat hearing loss by direct stimulation of the cochlea and conduct sound through the bone. Medical literature suggests that the optimal time for implanting these hearing aids is 2 to 4 years, the authors write, but this is not common. For example, the U.S. Food and Drug Administration of the equipment to be used only in children older than 5 years ..Over Sanofi AventisSanofi – aventis, a leading global pharmaceutical companies, contributes to improving life quality through the provision of a wide range by drugs, vaccines , and integral solutions to the healthcare to meet local needs and means.
The ATHENA stroke post-hoc analysis of on a non – pre-specified secondary end point of is performed in order the consequent Use of Multaq patients with atrial fibrillation or atrial flutter patients to reduce of major cardiovascular events such as stroke, being to verify one of said main reasons for cardiovascular hospitalization or death in this patient population.